New supplement MB-1 aims to shed pounds in overweight adults
NCT ID NCT07363148
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests whether a dietary supplement called MB-1 can help overweight and obese adults lose weight and improve metabolic health. One hundred participants will take either MB-1 or a placebo daily for 84 days. Researchers will measure changes in body weight, BMI, and other health markers to see if MB-1 is safe and effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MB-1 (dietary supplement)
What this could lead to
If it works, this could offer a new dietary supplement to help with weight loss and improve metabolic health in overweight adults.
What could go wrong
This is an early-stage trial with only 100 participants, so results may not apply to everyone. The supplement may not cause significant weight loss compared to placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BODY WEIGHT CONTROL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
KGK Science Inc.
London, Ontario, N6B3L1, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••